SCHEMBL2905520

SCHEMBL2905520

NS(=O)(=O)c1ccccc1S(=O)(=O)NC(=O)C1CCC(Cc2cc3ccccc3o2)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES2 Q9H7Z7 3/20 0.40
RAB9A P51151 3/20 0.40
KDM4E B2RXH2 2/20 0.40
NPC1 O15118 2/20 0.40
CYP1A2 P05177 1/20 0.40
MAOB P27338 1/20 0.40
CYP2C19 P33261 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
HDAC9 Q9UKV0 1/20 0.39
HDAC5 Q9UQL6 1/20 0.39
CA2 P00918 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL979172 0.82 RAB9A (0.44) PTGES2RAB9AKDM4ENPC1CYP1A2
SCHEMBL977742 0.82 RAB9A (0.44) PTGES2RAB9AKDM4ENPC1CYP1A2
SCHEMBL13618595 0.82 RAB9A (0.44) PTGES2RAB9AKDM4ENPC1CYP1A2
SCHEMBL2906664 0.75 VCP (0.45) SLC6A2SLC6A4LOXL2ADRA2AESR1
SCHEMBL7791747 0.73 LOXL2 (0.56) CA2SLC6A4LOXL2ADRA2AESR1
SCHEMBL2801464 0.68 PTGES (0.47) PTGES2RAB9AHDAC6PTGES
SCHEMBL976925 0.67 ACHE (0.40) PTGES2RAB9AKDM4ENPC1CYP1A2
SCHEMBL13618596 0.67 ACHE (0.40) PTGES2RAB9AKDM4ENPC1CYP1A2
SCHEMBL976926 0.67 ACHE (0.40) PTGES2RAB9AKDM4ENPC1CYP1A2
SCHEMBL10366180 0.67 LOXL2 (0.51) RAB9AKDM4ENPC1CYP1A2MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2217566-A1 BIS-(SULFONYLAMINO) DERIVATIVES IN THERAPY 066 AstraZeneca AB (SE) 2010-08-18 EP claimed
WO-2009064251-A1 BIS-(SULFONYLAMINO) DERIVATIVES IN THERAPY 066 ASTRAZENECA AB (SE) 2009-05-22 WO claimed
EP-2217566-A1 BIS-(SULFONYLAMINO) DERIVATIVES IN THERAPY 066 AstraZeneca AB (SE) 2010-08-18 EP disclosed
WO-2009064250-A1 BIS-(SULFONYLAMINO) DERIVATIVES IN THERAPY 065 ASTRAZENECA AB (SE) 2009-05-22 WO disclosed
WO-2009064251-A1 BIS-(SULFONYLAMINO) DERIVATIVES IN THERAPY 066 ASTRAZENECA AB (SE) 2009-05-22 WO disclosed